HK1138200A1 - Drug for preventing and or treating fatty liver or nonalcoholic fatty liver disease - Google Patents

Drug for preventing and or treating fatty liver or nonalcoholic fatty liver disease

Info

Publication number
HK1138200A1
HK1138200A1 HK10104346.1A HK10104346A HK1138200A1 HK 1138200 A1 HK1138200 A1 HK 1138200A1 HK 10104346 A HK10104346 A HK 10104346A HK 1138200 A1 HK1138200 A1 HK 1138200A1
Authority
HK
Hong Kong
Prior art keywords
fatty liver
drug
preventing
treating
nonalcoholic
Prior art date
Application number
HK10104346.1A
Other languages
English (en)
Chinese (zh)
Inventor
Yuji Yoshikawa
Megumi Yamamoto
Naoto Ishibashi
Mami Seki
Original Assignee
Kowa Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kowa Co filed Critical Kowa Co
Publication of HK1138200A1 publication Critical patent/HK1138200A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK10104346.1A 2007-03-30 2010-05-03 Drug for preventing and or treating fatty liver or nonalcoholic fatty liver disease HK1138200A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2007090114 2007-03-30
PCT/JP2008/000760 WO2008126363A1 (fr) 2007-03-30 2008-03-27 Médicament contre la stéatose hépatique ou les hépatites graisseuses non dues à l'alcool

Publications (1)

Publication Number Publication Date
HK1138200A1 true HK1138200A1 (en) 2010-08-20

Family

ID=39863523

Family Applications (1)

Application Number Title Priority Date Filing Date
HK10104346.1A HK1138200A1 (en) 2007-03-30 2010-05-03 Drug for preventing and or treating fatty liver or nonalcoholic fatty liver disease

Country Status (8)

Country Link
US (2) US20100120914A1 (fr)
EP (1) EP2143430B1 (fr)
JP (2) JP5341749B2 (fr)
KR (1) KR101461252B1 (fr)
CN (1) CN101652134B (fr)
ES (1) ES2555782T3 (fr)
HK (1) HK1138200A1 (fr)
WO (1) WO2008126363A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5725491B2 (ja) * 2010-04-14 2015-05-27 国立大学法人鳥取大学 レチノイン酸受容体リガンドによるインスリン抵抗性改善作用
JP5304939B1 (ja) * 2012-05-31 2013-10-02 大日本印刷株式会社 光学積層体、偏光板、偏光板の製造方法、画像表示装置、画像表示装置の製造方法及び画像表示装置の視認性改善方法
GB201301626D0 (en) * 2013-01-30 2013-03-13 Dignity Sciences Ltd Composition comprising 15-OHEPA and methods of using the same
EP2808031A1 (fr) * 2013-05-30 2014-12-03 Fundació Hospital Universitari Vall d' Hebron - Institut de Recerca Globuline fixatrices d'hormones sexuelles pour une utilisation comme médicament

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56140949A (en) * 1980-04-07 1981-11-04 Eisai Co Ltd 3,7,11,15-tetramethyl-2,4,6,10,14-hexadecapentaenic acid
JPS57106638A (en) * 1980-12-24 1982-07-02 Eisai Co Ltd Conjugated polyprenylcarboxylic acid and its derivative
JPS6332058A (ja) 1986-07-22 1988-02-10 株式会社　梅彦 石材の床張り方法
US5922345A (en) * 1990-12-07 1999-07-13 Scotia Holdings Plc Nutrition
GB9026648D0 (en) * 1990-12-07 1991-01-23 Efamol Holdings Nutrition
JPH09194362A (ja) * 1996-01-19 1997-07-29 Bizen Kasei Kk ドコサヘキサエン酸及びエイコサペンタエン酸含有リン脂質を含む組成物
DE60142038D1 (de) * 2000-04-24 2010-06-17 Kowa Co Aktivatoren des peroxisome proliferator-activated rezeptors
JP2002104965A (ja) * 2000-09-27 2002-04-10 Kanegafuchi Chem Ind Co Ltd 脂肪肝予防・改善機能を有する組成物
CN100428932C (zh) * 2002-05-17 2008-10-29 日研化学株式会社 TGF-α表达抑制剂
JP2004290821A (ja) 2003-03-27 2004-10-21 Aichi Electric Co Ltd 混合装置
EP1733723B1 (fr) * 2004-02-25 2011-07-13 The University of Tokyo Medicament capable d'inhiber l'activation du facteur de transcription klf5
JP2006232711A (ja) * 2005-02-24 2006-09-07 Tohoku Univ 血中中性脂肪低下作用および肝臓中性脂肪合成抑制作用および血小板凝集抑制作用を有する油脂
JP5099808B2 (ja) * 2006-05-29 2012-12-19 独立行政法人農業・食品産業技術総合研究機構 脂質代謝改善用組成物
JP2008150307A (ja) 2006-12-15 2008-07-03 Kenko Tsusho Kk 体脂肪の蓄積に起因する疾患の治療剤

Also Published As

Publication number Publication date
JP2013216679A (ja) 2013-10-24
KR20100015986A (ko) 2010-02-12
JPWO2008126363A1 (ja) 2010-07-22
WO2008126363A1 (fr) 2008-10-23
US20100120914A1 (en) 2010-05-13
EP2143430A4 (fr) 2010-12-29
US20120259015A1 (en) 2012-10-11
CN101652134B (zh) 2015-07-15
ES2555782T3 (es) 2016-01-08
JP5341749B2 (ja) 2013-11-13
KR101461252B1 (ko) 2014-11-12
EP2143430B1 (fr) 2015-09-23
US8673976B2 (en) 2014-03-18
EP2143430A1 (fr) 2010-01-13
CN101652134A (zh) 2010-02-17

Similar Documents

Publication Publication Date Title
HK1215533A1 (zh) 治療脂肪肝疾病的方法
HK1212598A1 (zh) 用於預防口腔疾病的組合物及方法
EP1962873A4 (fr) Compositions pharmaceutiques et méthodes destinées à traiter ou prévenir une maladie associée à l'oxalate
GB0621452D0 (en) Therapy for liver disease
EP1987141A4 (fr) Compositions et procédés de traitement des maladies médiées par le collagène
EP1872724A4 (fr) Ultrasonographe et procede de creation d'ultrasonogramme
PL2578081T4 (pl) Kompozycje, sposoby i urządzenia do leczenia chorób wątroby
ZA201102035B (en) Methods and formulations for treating chronic liver disease
EP2170311A4 (fr) Compositions et procédés pour traiter ou empêcher des maladies auto-immunes
EP2549997A4 (fr) Composition pharmaceutique pour la prévention ou le traitement d'une stéatose hépatique non alcoolique et procédé pour la prévention ou le traitement de la stéatose hépatique non alcoolique utilisant celle-ci
EP1974750A4 (fr) Agent preventif ou therapeutique et procede destine a une maladie immunitaire
HK1245679A1 (zh) 用於治療皮膚疾病和病症的方法和組合物
EP1971354A4 (fr) Composition a base de liquiritigenine pour la prevention et le traitement des maladies hepatiques
EP2069391A4 (fr) Compositions et methodes destinees a traiter et/ou a prevenir des maladies ophtalmologiques
EP2091545A4 (fr) Composition comprenant un extrait d'herbes combinées utilisée pour prévenir et traiter des maladies hépatiques
SI2234631T1 (sl) Spojine in postopki za zdravljenje ĺ˝ilne bolezni
EP2231148A4 (fr) Composition pharmaceutique utilisée dans le traitement et la prévention d'une maladie cardiaque
IL195771A0 (en) Methods and immune modulatory nucleic acid compositions for preventing and treating disease
HK1129596A1 (en) Methods and compositions for treating disease
HK1138200A1 (en) Drug for preventing and or treating fatty liver or nonalcoholic fatty liver disease
EP2199381A4 (fr) Système pour la formation et la maintenance d'un tissu biologique
EP1970078A4 (fr) Composition inhibant l'expression d'un gene cible du globe oculaire et remede pour une maladie du globe oculaire
GB0620695D0 (en) Composition and methods for the treatment of nurdegenerative disease
EP2005964A4 (fr) Médicament pour traiter l'hyperphosphatémie et son procédé de préparation
GB0603901D0 (en) Cancer imaging and treatment

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20200327